A Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR for Treatment of Recurrent and/or Refractory Meningiomas

Overview of attention for article published in Frontiers in Neurology, May 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

news: 1 news outlet

twitter: 2 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 17 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

A Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR for Treatment of Recurrent and/or Refractory Meningiomas

MyNeuroNews, 06 May 2020

Background: Meningiomas are the most common adult primary intracranial tumors in the United States.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.